Does TOFACITINIB Cause Middle insomnia? 179 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 179 reports of Middle insomnia have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.1% of all adverse event reports for TOFACITINIB.
179
Reports of Middle insomnia with TOFACITINIB
0.1%
of all TOFACITINIB reports
2
Deaths
21
Hospitalizations
How Dangerous Is Middle insomnia From TOFACITINIB?
Of the 179 reports, 2 (1.1%) resulted in death, 21 (11.7%) required hospitalization, and 1 (0.6%) were considered life-threatening.
Is Middle insomnia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 179 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Middle insomnia?
OMALIZUMAB (1,115)
SODIUM OXYBATE (924)
DUPILUMAB (633)
ALBUTEROL (578)
MONTELUKAST (417)
TASIMELTEON (412)
TIOTROPIUM (373)
BUDESONIDE\FORMOTEROL (371)
PREDNISONE (370)
CARBIDOPA\LEVODOPA (328)
Which TOFACITINIB Alternatives Have Lower Middle insomnia Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN